KEI Contributor

Jerome H. Kim, M.D., is the Director General of IVI and an international expert on the development and evaluation of vaccines.

Prior to IVI, he served as the Principal Deputy, US Military HIV Research Program and the Chief, Laboratory of Molecular Virology and Pathogenesis at the Walter Reed Army Institute of Research; and the US Army Program Manager for HIV vaccines. He led the Army’s RV144 Phase III HIV vaccine trial that showed efficacy in the prevention of HIV-1.

Dr. Kim is an Adjunct Professor, Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, USA; Adjunct Professor, Graduate School of Public Health, Yonsei University, Republic of Korea; and an Honorary Professor, University of Rwanda. He was also named a Distinguished Visiting Professor, Seoul National University in 2022. He has authored over 350 publications.

Dr. Kim is a graduate of the University of Hawaii with high honors in History and highest honors in Biology, received his M.D. from the Yale University School of Medicine, and trained in Internal Medicine and Infectious Diseases at Duke University Medical Center.

Dr. Kim has received numerous awards: John Maher Award for Research Excellence, Uniformed Services University (2013); Department of the Army Research and Development Achievement Award for Technical Excellence (2013); Asia Pacific Vaccine Excellence Lifetime Achievement Award (2021); Medal of Honor for Civil Merit from the Government of the Republic of Korea (2022).

https://www.ivi.int/who-we-are/leadership/jerome-h-kim/